Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Completed · Not applicable

Conditions studied: Cancer

In brief

RATIONALE: Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells can make an immune response against the body's normal tissues. Stem cells that have been treated in the laboratory to remove lymphocytes may prevent this from happening. PURPOSE: Clinical trial to prevent graft-versus-host disease in patients undergoing bone marrow transplantation.

Key facts

Study ID

NCT00003538

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Starts

1997-03-01

Expected to finish

2004-05-01

Last updated by the study team

2014-05-02

Who can join

Age: any, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.